Premium
Potent anti‐mycobacterial and immunomodulatory activity of some bioactive molecules of Indian ethnomedicinal plants that have the potential to enter in TB management
Author(s) -
Sarangi A.,
Das B.S.,
Patnaik G.,
Sarkar S.,
Debnath M.,
Mohan M.,
Bhattacharya D.
Publication year - 2021
Publication title -
journal of applied microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 156
eISSN - 1365-2672
pISSN - 1364-5072
DOI - 10.1111/jam.15088
Subject(s) - tuberculosis , mycobacterium tuberculosis , antibiotics , medicine , infectious disease (medical specialty) , pathogen , human pathogen , immune system , population , disease , biology , immunology , microbiology and biotechnology , bacteria , environmental health , genetics , pathology
Summary Tuberculosis (TB) is one of the deadliest infectious diseases of human civilization. Approximately one‐third of global population is latently infected with the TB pathogen Mycobacterium tuberculosis ( M.tb ). The discovery of anti‐TB antibiotics leads to decline in death rate of TB. However, the evolution of antibiotic‐resistant M.tb ‐strain and the resurgence of different immune‐compromised diseases re‐escalated the death rate of TB. WHO has already cautioned about the chances of pandemic situation in TB endemic countries until the discovery of new anti‐tubercular drugs, that is, the need of the hour. Analysing the pathogenesis of TB, it was found that M.tb evades the host by altering the balance of immune response and affects either by killing the cells or by creating inflammation. In the pre‐antibiotic era, traditional medicines were only therapeutic measures for different infectious diseases including tuberculosis. The ancient literatures of India or ample Indian traditional knowledge and ethnomedicinal practices are evidence for the treatment of TB using different indigenous plants. However, in the light of modern scientific approach, anti‐TB effects of those plants and their bioactive molecules were not established thoroughly. In this review, focus has been given on five bioactive molecules of different traditionally used Indian ethnomedicinal plants for treatment of TB or TB‐like symptom. These compounds are also validated with proper identification and their mode of action with modern scientific approaches. The effectiveness of these molecules for sensitive or drug‐resistant TB pathogen in clinical or preclinical studies was also evaluated. Thus, our specific aim is to highlight such scientifically validated bioactive compounds having anti‐mycobacterial and immunomodulatory activity for future use as medicine or adjunct‐therapeutic molecule for TB management.